Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/genie-pharmaceutique/usp41-nf36-2018-print-subscription/descriptif_3639750
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3639750

USP41-NF36 (2018) (Print subscription) (5 volume set with 2 supplements published in February & June 2018) (2410001)

Langue : Anglais
USP-NF is a combination of two compendia, the United States Pharmacopeia (USP) and the National Formulary (NF). It contains standards for medicines, dosage forms, drug substances, excipients, biologics, compounded preparations, medical devices, dietary supplements, and other therapeutics.

USP 41 - NF 36 will come into force on 1st May 2018. It will be enforceable by the U.S. Food and Drug Administration for medicines manufactured and marketed in the United States.

The USP–NF offers convenient, comprehensive information for all phases of producing quality prescription, nonprescription, and compounded medicines; excipients; biologics; medical devices; and dietary supplements. It is essential for quality control, quality assurance, regulatory/compendial affairs, research and development, method development/analytical services, and corporate management. USP–NF monographs and methods can help to:

- Ensure compliance with required U.S. quality standards
- Work to world-recognized standards of precision and accuracy
- Validate test results against proven benchmarks
- Establish and validate in-house standard operating procedures, and specifications
- Expedite new product development and approvals

Date de parution :

Disponible chez l'éditeur (délai d'approvisionnement : 5 jours).

Prix indicatif 1343,82 €

Ajouter au panier

Thème d’USP41-NF36 (2018) (Print subscription)  :

En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.
FERMER